Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RWT
2551
Redwood Trust
RWT
$592M
| $10.1M | ﹤0.01% |
1,489,803
-50,689
| -3% | -$354K |
|
|
SLN
2552
Silence Therapeutics
SLN
$557M
| $10.1M | ﹤0.01% |
660,189
+189
| +0% | +$2.48K |
|
2553
Biohaven
BHVN
$2.2B
| $10.1M | ﹤0.01% |
+724,882
| New | +$10.2M |
|
|
AGAC
2554
DELISTED
African Gold Acquisition Corp
AGAC
| $10.1M | ﹤0.01% |
1,000,299
-4
| -0% | -$40 |
|
2555
Armstrong World Industries
AWI
$7.87B
| $10M | ﹤0.01% |
146,371
-26,733
| -15% | -$2.02M |
|
2556
AtriCure
ATRC
$2.06B
| $10M | ﹤0.01% |
225,480
+117,476
| +109% | +$4.91M |
|
2557
United States Oil Fund
USO
$1.87B
| $9.98M | ﹤0.01% |
142,351
-51,646
| -27% | -$3.61M |
|
|
PDCO
2558
DELISTED
Patterson Companies, Inc.
PDCO
| $9.97M | ﹤0.01% |
355,644
-68,700
| -16% | -$1.9M |
|
|
GOLD
2559
Gold.com Inc
GOLD
$1.26B
| $9.96M | ﹤0.01% |
286,879
+89,698
| +45% | +$2.84M |
|
2560
TriNet
TNET
$3.16B
| $9.96M | ﹤0.01% |
146,932
-26,911
| -15% | -$1.86M |
|
|
SIRE
2561
DELISTED
Sisecam Resources LP
SIRE
| $9.96M | ﹤0.01% |
474,132
-77,903
| -14% | -$1.7M |
|
2562
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$593M
| $9.95M | ﹤0.01% |
104,927
-38,008
| -27% | -$3.67M |
|
|
SWTX
2563
DELISTED
SpringWorks Therapeutics
SWTX
| $9.94M | ﹤0.01% |
382,188
-103,165
| -21% | -$2.54M |
|
2564
PUT
Credit Acceptance
CACC
$5.98B
| $9.91M | ﹤0.01% |
+20,900
| New | +$9.59M |
|
|
JKS
2565
JinkoSolar
JKS
$892M
| $9.91M | ﹤0.01% |
242,493
-4,688
| -2% | -$226K |
|
2566
uniQure
QURE
$3.13B
| $9.89M | ﹤0.01% |
436,156
-34,326
| -7% | -$740K |
|
|
ZH
2567
Zhihu
ZH
$279M
| $9.88M | ﹤0.01% |
1,267,136
-200,693
| -14% | -$1.41M |
|
2568
CALL
DoorDash
DASH
$95.6B
| $9.88M | ﹤0.01% |
202,400
-171,300
| -46% | -$8.89M |
|
2569
Adaptive Biotechnologies
ADPT
$3.9B
| $9.86M | ﹤0.01% |
1,290,575
-616,014
| -32% | -$4.79M |
|
|
TSVT
2570
DELISTED
2seventy bio
TSVT
| $9.85M | ﹤0.01% |
1,051,143
-7,076
| -0.7% | -$99.8K |
|
2571
CALL
Carnival Corporation Ltd
CCL
$39.3B
| $9.82M | ﹤0.01% |
1,218,700
+205,900
| +20% | +$1.77M |
|
2572
Bloomin' Brands
BLMN
$943M
| $9.81M | ﹤0.01% |
487,386
-417,264
| -46% | -$9.04M |
|
2573
CALL
Marvell Technology
MRVL
$195B
| $9.79M | ﹤0.01% |
+264,200
| New | +$10.8M |
|
2574
KB Financial Group
KB
$43.3B
| $9.77M | ﹤0.01% |
252,601
+62,666
| +33% | +$2.26M |
|
2575
Globant
GLOB
$1.59B
| $9.76M | ﹤0.01% |
58,018
-30,544
| -34% | -$5.41M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.